Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | RARB | P10826 | 1/20 | 0.57 |
| ▸ | RARG | P13631 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | MIF | P14174 | 1/20 | 0.55 |
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28521094 | 0.96 | RARB (0.54) | ALOX5RARBRARGALDH1A1ALOX15 | |
| SCHEMBL16581393 | 0.90 | ALDH1A1 (0.57) | ALOX5RARBRARGALDH1A1ALOX15 | |
| SCHEMBL31146788 | 0.89 | ALDH1A1 (0.67) | RARBRARGALDH1A1ALOX15LMNA | |
| SCHEMBL1176397 | 0.89 | ALDH1A1 (0.67) | RARBRARGALDH1A1ALOX15LMNA | |
| SCHEMBL9167807 | 0.87 | ALDH1A1 (0.57) | ALOX5RARBRARGALDH1A1ALOX15 | |
| SCHEMBL1237149 | 0.86 | ALDH1A1 (0.69) | ALOX5RARBRARGALDH1A1ALOX15 | |
| SCHEMBL2721125 | 0.86 | ALDH1A1 (0.69) | ALOX5RARBRARGALDH1A1ALOX15 | |
| Biphenyl SCHEMBL28011227 | 0.85 | ALDH1A1 (0.53) | ALOX5RARBRARGALDH1A1ALOX15 | |
| Biphenyl SCHEMBL28492519 | 0.85 | ALDH1A1 (0.53) | ALOX5RARBRARGALDH1A1ALOX15 | |
| SCHEMBL6878804 | 0.84 | ALOX5 (0.57) | ALOX5RARBRARGALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114957152-B | Synthesis method of benzoxazole compound | 湖南第一师范学院 | 2023-11-17 | — | — | CN | claimed |
| CN-114957152-A | Synthetic method of benzoxazole compound | 湖南第一师范学院 | 2022-08-30 | — | — | CN | claimed |
| EP-0852486-A2 | ANTIPLAQUE ORAL COMPOSITION | Colgate-Palmolive Company (US) | 1998-07-15 | — | — | EP | claimed |
| US-5723500-A | WATER INSOLUBLE, NONCATIONIC, ANTIBACTERIAL, STERICALLY HINDERED PHENOL; MOUTHWASHES, DENTIFRICES | COLGATE-PALMOLIVE COMPANY (US) | 1998-03-03 | — | — | US | claimed |
| WO-1997010800-A2 | ANTIPLAQUE ORAL COMPOSITION | COLGATE-PALMOLIVE COMPANY (US) | 1997-03-27 | — | — | WO | claimed |
| CN-114957152-B | Synthesis method of benzoxazole compound | 湖南第一师范学院 | 2023-11-17 | — | — | CN | disclosed |
| CN-114957152-A | Synthetic method of benzoxazole compound | 湖南第一师范学院 | 2022-08-30 | — | — | CN | disclosed |
| US-20210299095-A1 | METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE | CASE WESTERN RESERVE UNIVERSITY | 2021-09-30 | — | — | US | disclosed |
| CN-112293502-A | Carbon quantum dot antioxidant, preparation method thereof and application thereof in frying oil | 江南大学 | 2021-02-02 | — | — | CN | disclosed |
| US-7842825-B2 | Biaryloxymethylarenecarboxylic acids as glycogen synthase activator | HOFFMANN-LA ROCHE INC. (US) | 2010-11-30 | — | — | US | disclosed |
| US-7700632-B2 | Biaryloxymethylarenecarboxylic acids as glycogen synthase activator | HOFFMANN-LA ROCHE INC. (US) | 2010-04-20 | — | — | US | disclosed |
| US-7534539-B2 | Electrophotographic photoreceptor and image forming apparatus having the same | SHARP KABUSHIKI KAISHA (JP) | 2009-05-19 | — | — | US | disclosed |
| EP-0518241-B1 | Hydroformylation process and bisphosphite compound used therein | MITSUBISHI CHEM CORP (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-5446213-A | Dimerizing lower olefin in presence of catalyst containing nickel compound, organic aluminum compound, specified alkyl substituted phenyl phosphite | MITSUBISHI KASEI CORPORATION (JP) | 1995-08-29 | — | — | US | disclosed |
| EP-0518241-A2 | Hydroformylation process and bisphosphite compound used therein | Mitsubishi Chemical Corporation (JP) | 1992-12-16 | — | — | EP | disclosed |
| US-4247427-A | Adhesion promoted block copolyester composition with multi-functional carboxylic compound | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-01-27 | — | — | US | disclosed |
| US-4156702-A | Adhesion promoted block copolyester composition with multi-functional carboxylic compound | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-05-29 | — | — | US | disclosed |
| US-4107138-A | Phosphonous and thiophosphonous acid ethers as stabilizers for organic materials | SANDOZ LTD. (CH) | 1978-08-15 | — | — | US | disclosed |
| US-4048128-A | ALKALINE EARTH OXIDE, POLYCARBODIIMIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-09-13 | — | — | US | disclosed |
| US-3969294-A | Segmented copolyester adhesives stabilized by alkaline earth oxides and carboxylic compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299095-A1 | METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE | RRM2, RRM2B, RRM1 | ALOX5 887/4885RARB 154/4885RARG 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.